Brequinar

From WikiMD.org
Jump to navigation Jump to search

Brequinar (pronounced breh-KWIN-ar) is a type of antineoplastic agent that is used in the treatment of various types of cancer. It is a dihydroorotate dehydrogenase inhibitor, which means it works by blocking the action of an enzyme that is necessary for the growth of cancer cells.

Etymology

The term "Brequinar" is derived from the chemical name of the drug, which is 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid. The "-quin-" in the name refers to the quinoline part of the molecule, while the "-ar" at the end is a common suffix used in the names of drugs.

Usage

Brequinar is used in the treatment of a variety of cancers, including leukemia, lymphoma, and solid tumors. It is usually administered intravenously, and the dosage and frequency of administration depend on the type and stage of the cancer being treated.

Related Terms

  • Antineoplastic agent: A type of drug that inhibits the growth and spread of cancer cells.
  • Dihydroorotate dehydrogenase: An enzyme that is involved in the synthesis of pyrimidines, which are essential components of DNA and RNA.
  • Leukemia: A type of cancer that affects the blood and bone marrow.
  • Lymphoma: A type of cancer that begins in the cells of the immune system.
  • Solid tumor: A type of cancer that begins in the cells of a specific organ or tissue.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski